<DOC>
	<DOCNO>NCT02892227</DOCNO>
	<brief_summary>Our hypothesis : daily bedside echocardiographic assessment , protocolized , simple , filling pressure evaluation mitral inflow inferior vena cava , allow reliable estimate true blood volume patient thus lead therapeutic adjustment suitable . This therapeutic adjustment closer patient 's need would impact few readmission 30 day mortality , less alteration biological parameter myocardial , kidney liver .</brief_summary>
	<brief_title>Management Acute Heart Failure : Contribution Ultrasound Daily `` Bed Patient '' Adjustment Therapy With Impact Measure Hospital Rate During 30 Days</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>The patient representative must give free informed consent sign consent . The patient must affiliate beneficiary health insurance plan . The patient available followup 6 month . The patient age older ( &gt; ) 18 . Patients hospitalize acute heart failure receive least 40mg furosemide IV . Patient impair LVEF &lt; 50 % . Patient NtproBNP value &gt; 1200pg / ml . The subject take part another study . The subject exclusion period determine previous study . The subject judicial protection . The subject representative refuse sign consent . It possible give subject representative inform information . Noninclusion criterion diseases condition associate ( ) interfere ( ) : The patient pregnant breastfeeding . The patient already include surveillance program ( PRADO , OSICAT ) . Patient mechanical biological mitral prosthesis . History mitral stenosis . severe valvular surgery maturity month ( &lt; 30 day ) . chronic renal impairment dialysis . High grade AV block ( AVB BAV3 2/1 ) . Hypertrophic cardiomyopathy . Cardiogenic shock . Contraindications furosemide .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>bedside echography</keyword>
</DOC>